HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced bendamustine for elderly patients with follicular lymphoma.

AuthorsYosuke Masamoto, Arika Shimura, Mineo Kurokawa
JournalAnnals of hematology (Ann Hematol) Vol. 101 Issue 3 Pg. 713-715 (Mar 2022) ISSN: 1432-0584 [Electronic] Germany
PMID34152427 (Publication Type: Letter)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Bendamustine Hydrochloride
Topics
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents, Alkylating (administration & dosage, therapeutic use)
  • Bendamustine Hydrochloride (administration & dosage, therapeutic use)
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Lymphoma, Follicular (drug therapy, epidemiology)
  • Male
  • Middle Aged
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: